FDA Benefits Under U.S.-EU MRA Unclear, Rep. Barton Suggests
This article was originally published in The Tan Sheet
Executive Summary
FDA appears to gain no proven long-term benefits from the U.S.-European Union Good Manufacturing Practices regulations mutual recognition agreement, House Commerce/Oversight Subcommittee Chairman Joe Barton (R.-Tex.) suggested during a hearing Oct. 2.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning